Journal of Hepatology
Volume 49, Issue 2 , Pages 184-191 , August 2008

Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis C

  • Xiaowen Su

      Affiliations

    • Medical Genetics Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA
    • ,
  • Leland J. Yee

      Affiliations

    • Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, A511 Crabtree Hall, 130 DeSoto Street, Pittsburgh, PA 15232, USA
    • Division of Infectious Diseases, Department of Medicine, School of Medicine, University of Pittsburgh, A511 Crabtree Hall, 130 DeSoto Street, Pittsburgh, PA, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 412 624 5326; fax: +1 412 624 7397.
    • ,
  • KyungAh Im

      Affiliations

    • Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, A511 Crabtree Hall, 130 DeSoto Street, Pittsburgh, PA 15232, USA
    • Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA
    • ,
  • Shannon L. Rhodes

      Affiliations

    • Medical Genetics Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA
    • ,
  • YongMing Tang

      Affiliations

    • Medical Genetics Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA
    • ,
  • Xiaomei Tong

      Affiliations

    • Medical Genetics Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA
    • ,
  • Charles Howell

      Affiliations

    • Department of Medicine, Division of Gastroenterology and Hepatology, University of Maryland, School of Medicine, Baltimore, MD, USA
    • ,
  • Darmendra Ramcharran

      Affiliations

    • Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, A511 Crabtree Hall, 130 DeSoto Street, Pittsburgh, PA 15232, USA
    • ,
  • Hugo R. Rosen

      Affiliations

    • Integrated Program in Immunology and Hepatitis C Research Center, Division of Gastroenterology & Hepatology, University of Colorado, Denver, CO, USA
    • ,
  • Milton W. Taylor

      Affiliations

    • Department of Biology, Indiana University, Bloomington, IN, USA
    • ,
  • T. Jake Liang

      Affiliations

    • Division of Digestive Diseases, NIDDK, National Institutes of Health, Bethesda, MD, USA
    • ,
  • Huiying Yang

      Affiliations

    • Medical Genetics Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA
    • Present address: Department of Patient Safety and Global Epidemiology, AstraZeneca Pharmaceuticals LP, Wilmington, DE, USA.
    • ,
  • for the Virahep-C Study Group

Received 17 December 2007 ,Revised 18 March 2008 ,Accepted 17 April 2008.

References 

  1. Brown RS. Hepatitis C and liver transplantation. Nature. 2005;436:973–978
  2. Feld JJ, Hoofnagle JH. Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature. 2005;436:967–972
  3. Jeffers LJ. Treating hepatitis C in African Americans. Liver Int. 2007;27:313–322
  4. Gao B, Hong F, Radaeva S. Host factors and failure of interferon-alpha treatment in hepatitis C virus. Hepatology. 2004;39:880–890
  5. Sen GC. Viruses and interferons. Annu Rev Microbiol. 2001;55:255–281
  6. Zhang Y, Jamaluddin M, Wang S, Tian B, Garofalo RP, Casola A, et al. Ribavirin treatment up-regulates antiviral gene expression via the interferon-stimulated response element in respiratory syncytial virus-infected epithelial cells. J Virol. 2003;77:5933–5947
  7. Giannelli G, Guadagnino G, Dentico P, Antonelli G, Antonaci S. MxA and PKR expression in chronic hepatitis C. J Interferon Cytokine Res. 2004;24:659–663
  8. Bigger CB, Guerra B, Brasky KM, Hubbard G, Beard MR, Luxon BA, et al. Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees. J Virol. 2004;78:13779–13792
  9. Chen L, Borozan I, Feld J, Sun J, Tannis LL, Coltescu C, et al. Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection. Gastroenterology. 2005;128:1437–1444
  10. Di Bona D, Cippitelli M, Fionda C, Cammà C, Licata A, Santoni A, et al. Oxidative stress inhibits IFN-alpha-induced antiviral gene expression by blocking the JAK-STAT pathway. J Hepatol. 2006;45:271–279
  11. Luo S, Cassidy W, Jeffers L, Reddy KR, Bruno C, Howell CD, et al. Interferon-stimulated gene expression in black and white hepatitis C patients during peginterferon alfa-2a combination therapy. Clin Gastroenterol Hepatol. 2005;3:499–506
  12. Knapp S, Yee LJ, Frodsham AJ, Hennig BJ, Hellier S, Zhang L, et al. Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR. Genes Immun. 2003;4:411–419
  13. Suzuki F, Arase Y, Suzuki Y, Tsubota A, Akuta N, Hosaka T, et al. Single nucleotide polymorphism of the MxA gene promoter influences the response to interferon monotherapy in patients with hepatitis C viral infection. J Viral Hepat. 2004;11:271–276
  14. Conjeevaram HS, Fried MW, Jeffers LJ, Terrault NA, Wiley-Lucas TE, Afdhal N, et al. Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1. Gastroenterology. 2006;131:470–477
  15. Goodarzi MO, Guo X, Taylor KD, Quiñones MJ, Samayoa C, Yang H, et al. Determination and use of haplotypes: ethnic comparison and association of the lipoprotein lipase gene and coronary artery disease in Mexican-Americans. Genet Med. 2003;5:322–327
  16. Yee LJ, Tang YM, Kleiner DE, Wang D, Im K, Wahed A, et al. Myxovirus-1 and protein kinase haplotypes and fibrosis in chronic hepatitis C virus. Hepatology. 2007;46:74–83
  17. Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. Genetics. 2000;155:945–959
  18. Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159:702–706
  19. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263–265
  20. Hijikata M, Mishiro S, Miyamoto C, Furuichi Y, Hashimoto M, Ohta Y. Genetic polymorphism of the MxA gene promoter and interferon responsiveness of hepatitis C patients: revisited by analyzing two SNP sites (−123 and −88) in vivo and in vitro. Intervirology. 2001;44:379–382
  21. Hijikata M, Ohta Y, Mishiro S. Identification of a single nucleotide polymorphism in the MxA gene promoter (G/T at nt −88) correlated with the response of hepatitis C patients to interferon. Intervirology. 2000;43:124–127
  22. Marie I, Rebouillat D, Hovanessian AG. The expression of both domains of the 69/71kDa 2′,5′ oligoadenylate synthetase generates a catalytically active enzyme and mediates an anti-viral response. Eur J Biochem. 1999;262:155–165
  23. Rebouillat D, Hovanessian AG. The human 2′,5′-oligoadenylate synthetase family: interferon-induced proteins with unique enzymatic properties. J Interferon Cytokine Res. 1999;19:295–308
  24. Hartmann R, Norby PL, Martensen PM, Jorgensen P, James MC, Jacobsen C, et al. Activation of 2′–5′ oligoadenylate synthetase by single-stranded and double-stranded RNA aptamers. J Biol Chem. 1998;273:3236–3246
  25. Yakub I, Lillibridge KM, Moran A, Gonzalez OY, Belmont J, Gibbs RA, et al. Single nucleotide polymorphisms in genes for 2′–5′-oligoadenylate synthetase and RNase L inpatients hospitalized with West Nile virus infection. J Infect Dis. 2005;192:1741–1748
  26. Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR. ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res. 2003;31:3568–3571
  27. Ryther RC, Flynt AS, Harris BD, Phillips JA, Patton JG. GH1 splicing is regulated by multiple enhancers whose mutation produces a dominant-negative GH isoform that can be degraded by allele-specific small interfering RNA (siRNA). Endocrinology. 2004;145:2988–2996
  28. Rosati M, Valentin A, Patenaude DJ, Pavlakis GN. CCAAT-enhancer-binding protein beta (C/EBP beta) activates CCR5 promoter: increased C/EBP beta and CCR5 in T lymphocytes from HIV-1-infected individuals. J Immunol. 2001;167:1654–1662
  29. Yang Y, Pares-Matos EI, Tesmer VM, Dai C, Ashworth S, Huai J, et al. Organization of the promoter region of the human NF-IL6 gene. Biochim Biophys Acta. 2002;1577:102–108

☆ This study was a cooperative agreement funded by the NIDDK and co-funded by the National Center on Minority Health and Health Disparities (NCMHD), with a Cooperative Research and Development Agreement (CRADA) with Roche Laboratories, Inc. Grant Nos. U01 DK60329, U01 DK60340, U01 DK60324, U01 DK60344, U01 DK60327, U01 DK60335, U01 DK60352, U01 DK60342, U01 DK60345, U01 DK60309, U01 DK60346, U01 DK60349, and U01 DK60341. Other support: National Center for Research Resources (NCRR), Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research, General Clinical Research Centers Program Grants: M01 RR00645 (New York Presbyterian), M02 RR000079 (University of California, San Francisco), M01 RR16500 (University of Maryland), M01 RR000042 (University of Michigan), and M01 RR00046 (University of North Carolina). Additional support was provided to L.J.Y. by 1KL2 RR024154-01. NIH funded study.

PII: S0168-8278(08)00292-4

doi: 10.1016/j.jhep.2008.04.011

Journal of Hepatology
Volume 49, Issue 2 , Pages 184-191 , August 2008

Article Tools